Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes
BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain. We aim to evaluate whether BMI will aff...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1493613/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823856499409027072 |
|---|---|
| author | Lulu Sun Zhuo Wang Bai Wang Yuxiang Jia Qidi Zhao Jingjun Zhao Xingtao Huang |
| author_facet | Lulu Sun Zhuo Wang Bai Wang Yuxiang Jia Qidi Zhao Jingjun Zhao Xingtao Huang |
| author_sort | Lulu Sun |
| collection | DOAJ |
| description | BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain. We aim to evaluate whether BMI will affect the lipid-lowing effects of statins in patients with T2DM.MethodsIn this retrospective analysis, we screened T2DM patients who were prescribed statins and underwent a 1-year outpatient follow-up recorded in the electronic medical record system. Patients were stratified into three groups: normal weight (BMI < 24 kg/m), overweight (24 kg/m2 ≤ BMI < 28 kg/m2), and obese (BMI ≥ 28 kg/m2). Lipid levels were assessed at two time points, and multivariate logistic regression analysis was used to identify factors influencing the reduction of low-density lipoprotein-cholesterol (LDL-C) levels and lipid control achievement.ResultsThis study included 289 patients, with 82 in normal weigh, 143 in overweight, and 64 in obese. Overweight and obese patients were found to be younger than those with normal weight. Over the 1-year follow-up period, lipid levels decreased in all patients, with a significant reduction observed in LDL-C levels. Notably, obese patients experienced the highest reduction in LDL-C levels compared to the normal and overweight groups (normal weight group ΔLDL 0.78 ± 0.95 mmol/L, p < 0.001; overweight group ΔLDL 0.80 ± 0.88 mmol/L, p < 0.001; obese group ΔLDL 1.11 ± 0.82 mmol/L, p < 0.038). Obese patients exhibited a remarkable 42.02% reduction in LDL levels (normal 27.45%, overweight 30.64%). Multivariate logistic regression analysis indicated that achieving lipid control, defined as LDL < 2.6 mmol/L, was more likely in obese patients compared to those with normal weight [odds ratio [OR] 3.48, 95% confidence interval [CI]: 1.18, 10.21, p = 0.023].ConclusionsThe effectiveness of statins in lowering lipid levels appears to be influenced by the patient's BMI in patients with T2DM. T2DM patients with high BMI may derive greater benefits, particularly in LDL reduction, from statin therapy. |
| format | Article |
| id | doaj-art-64f92d79d2794ed4aef5ae3eac884a93 |
| institution | Kabale University |
| issn | 2297-055X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj-art-64f92d79d2794ed4aef5ae3eac884a932025-02-12T07:26:36ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-02-011210.3389/fcvm.2025.14936131493613Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetesLulu Sun0Zhuo Wang1Bai Wang2Yuxiang Jia3Qidi Zhao4Jingjun Zhao5Xingtao Huang6Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Cardiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaBackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain. We aim to evaluate whether BMI will affect the lipid-lowing effects of statins in patients with T2DM.MethodsIn this retrospective analysis, we screened T2DM patients who were prescribed statins and underwent a 1-year outpatient follow-up recorded in the electronic medical record system. Patients were stratified into three groups: normal weight (BMI < 24 kg/m), overweight (24 kg/m2 ≤ BMI < 28 kg/m2), and obese (BMI ≥ 28 kg/m2). Lipid levels were assessed at two time points, and multivariate logistic regression analysis was used to identify factors influencing the reduction of low-density lipoprotein-cholesterol (LDL-C) levels and lipid control achievement.ResultsThis study included 289 patients, with 82 in normal weigh, 143 in overweight, and 64 in obese. Overweight and obese patients were found to be younger than those with normal weight. Over the 1-year follow-up period, lipid levels decreased in all patients, with a significant reduction observed in LDL-C levels. Notably, obese patients experienced the highest reduction in LDL-C levels compared to the normal and overweight groups (normal weight group ΔLDL 0.78 ± 0.95 mmol/L, p < 0.001; overweight group ΔLDL 0.80 ± 0.88 mmol/L, p < 0.001; obese group ΔLDL 1.11 ± 0.82 mmol/L, p < 0.038). Obese patients exhibited a remarkable 42.02% reduction in LDL levels (normal 27.45%, overweight 30.64%). Multivariate logistic regression analysis indicated that achieving lipid control, defined as LDL < 2.6 mmol/L, was more likely in obese patients compared to those with normal weight [odds ratio [OR] 3.48, 95% confidence interval [CI]: 1.18, 10.21, p = 0.023].ConclusionsThe effectiveness of statins in lowering lipid levels appears to be influenced by the patient's BMI in patients with T2DM. T2DM patients with high BMI may derive greater benefits, particularly in LDL reduction, from statin therapy.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1493613/fullbody mass indexstatinstype 2 diabetes mellituslow-density lipoprotein cholesterollipid |
| spellingShingle | Lulu Sun Zhuo Wang Bai Wang Yuxiang Jia Qidi Zhao Jingjun Zhao Xingtao Huang Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes Frontiers in Cardiovascular Medicine body mass index statins type 2 diabetes mellitus low-density lipoprotein cholesterol lipid |
| title | Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes |
| title_full | Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes |
| title_fullStr | Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes |
| title_full_unstemmed | Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes |
| title_short | Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes |
| title_sort | body mass index impacts the lipid lowing effects of statins in patients with type 2 diabetes |
| topic | body mass index statins type 2 diabetes mellitus low-density lipoprotein cholesterol lipid |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1493613/full |
| work_keys_str_mv | AT lulusun bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT zhuowang bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT baiwang bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT yuxiangjia bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT qidizhao bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT jingjunzhao bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes AT xingtaohuang bodymassindeximpactsthelipidlowingeffectsofstatinsinpatientswithtype2diabetes |